Stay updated with breaking news from Michael Zercher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roth Capital assumed coverage on shares of 22nd Century Group (NASDAQ:XXII – Get Rating) in a research report report published on Tuesday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $6.00 price target on the biotechnology company’s stock. Other research analysts also recently issued research reports about the company. Zacks Investment Research […]
Wall Street brokerages predict that 22nd Century Group, Inc. (NASDAQ:XXII – Get Rating) will post sales of $9.90 million for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for 22nd Century Group’s earnings, with the highest sales estimate coming in at $11.81 million and the lowest estimate coming in at […]
BUFFALO, N.Y., Jan. 03, 2022 -- 22nd Century Group, Inc. , a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and... | January 3, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation. 22nd Century Group Installs State-of-the-Art Nicotine Testing Equipment to Enhance VLN® Production 22nd Century Group, IncMay 5, 2021 GMT BUFFALO, N.Y., May 05, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that it is advancing and expanding capabilities in its in-house laboratory, located in its cigarette manufacturing faci...